Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof
Código 292231 (Harmonized System 2012 by 6 digits)
2019: US$831k, International Purchases
The states with the most international purchases in 2019 were Ciudad de México (US$831k).
The main commercial origins of Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof in 2019 were United States (US$505k), Germany (US$243k), and Italy (US$82.6k).
In the global context, the main exporting countries of Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof in 2022 were Switzerland (US$5.16M), Slovakia (US$1.94M), and India (US$1.26M). In the same year, the main importing countries of Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof were Australia (US$1.3M), United Kingdom (US$1.21M), and Italy (US$1.07M).
Trade Balance of Mexico
#permalink to sectionNet Trade Balance
#permalink to sectionThe visualizations show the net balance of Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
Net International Trade
#permalink to sectionAugust, 2011: US$42.1k, International Purchases
In August 2011, international sales of Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof were US$0, while international purchases reached US$42.1k. The above results in a trade balance of -US$42.1k.
Exchange by Territory
#permalink to sectionInternational Purchases
#permalink to sectionCiudad de México: US$831k, State with the Most International Purchases (2019)
United States: US$505k, Main Commercial Origin (2019)
In 2019, the states with the highest international in Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof were Ciudad de México (US$831k).
The countries with the most international sales to Mexico in 2019 were United States (US$505k), Germany (US$243k), and Italy (US$82.6k).
Specialization
#permalink to sectionSpecialization by State
#permalink to sectionThe RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
Global Market
#permalink to sectionOrigins and Trade Destinations
#permalink to section- 0%, Mexican share in global exports - 2022
- 1.06%, Mexican share in global imports - 2022
The visualizations show the global market for Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof were Switzerland (US$5.16M), Slovakia (US$1.94M), and India (US$1.26M). In the same year, the main importing countries for Amfepramone "Inn", Methadone "Inn" and Normethadone "Inn"; Salts Thereof were Australia (US$1.3M), United Kingdom (US$1.21M), and Italy (US$1.07M).